Grey Market Premium · May 12 – May 14, 2026 · Issue Price ₹43
Last updated:
The Goldline Pharmaceutical IPO GMP is ₹15.00, last updated on 19 May 2026, 11:25 AM IST, indicating 34.9% expected listing gain, or about ₹45,000 per lot of 3,000 shares.
The Goldline Pharmaceutical IPO Grey Market Premium (GMP) is currently trading at ₹15.00 in the unofficial grey market. Based on this, the expected listing price is ₹58.00, implying a +34.9% gain over the issue price of ₹43. GMP reflects pre-listing demand from grey market participants and is a widely tracked sentiment indicator among IPO investors.
Last recorded GMP of each day (IST), newest first. Est. listing = upper price band + GMP.
| Date | GMP (₹) | Change | Est. Listing | Profit / Lot | Trend |
|---|---|---|---|---|---|
| 19 May 2026 11:25 am | +₹15.00 (34.9%) | ₹0.00 | ₹58.00 | ₹45,000 | – Flat |
| 18 May 2026 12:02 pm | +₹15.00 (34.9%) | −₹5.00 | ₹58.00 | ₹45,000 | ▼ Down |
| 17 May 2026 2:34 pm | +₹20.00 (46.5%) | ₹0.00 | ₹63.00 | ₹60,000 | – Flat |
| 16 May 2026 1:19 pm | +₹20.00 (46.5%) | ₹0.00 | ₹63.00 | ₹60,000 | – Flat |
| 15 May 2026 10:46 am | +₹20.00 (46.5%) | +₹5.00 | ₹63.00 | ₹60,000 | ▲ Up |
| 14 May 2026 5:18 pm | +₹15.00 (34.9%) | −₹10.00 | ₹58.00 | ₹45,000 | ▼ Down |
| 13 May 2026 11:34 pm | +₹25.00 (58.1%) | +₹7.00 | ₹68.00 | ₹75,000 | ▲ Up |
| 12 May 2026 2:51 pm | +₹18.00 (41.9%) | +₹1.00 | ₹61.00 | ₹54,000 | ▲ Up |
| 11 May 2026 6:36 pm | +₹17.00 (39.5%) | +₹1.00 | ₹60.00 | ₹51,000 | ▲ Up |
| 10 May 2026 12:52 pm | +₹16.00 (37.2%) | +₹1.00 | ₹59.00 | ₹48,000 | ▲ Up |
| 9 May 2026 10:37 pm | +₹15.00 (34.9%) | +₹7.00 | ₹58.00 | ₹45,000 | ▲ Up |
| 8 May 2026 12:17 pm | +₹8.00 (18.6%) | +₹8.00 | ₹51.00 | ₹24,000 | ▲ Up |
| 7 May 2026 4:20 pm | +₹0.00 (0.0%) | — | ₹43.00 | ₹0 | — |
Over the last 5 days with GMP data (15 May – 19 May 2026), the Goldline Pharmaceutical IPO GMP moved from ₹20.00 to ₹15.00, a net change of −₹5.00 (−11.6% of the upper price band). It closed higher on 0, lower on 1 and unchanged on 3 of those days compared with the day before.
Plain calculations from our recorded entries. Rising = net change above +5% of the upper price band, falling = below −5%, stable = in between.
Grey market premium over time (₹)
13 entries recorded, newest first. Trend compares each entry with the one before it.
| # | Date / Time | GMP (₹) | Exp. Listing | Exp. Gain | Trend |
|---|---|---|---|---|---|
| 1 | May 19, 2026 11:25 am | +₹15.00 | ₹58.00 | +34.9% | – Flat |
| 2 | May 18, 2026 12:02 pm | +₹15.00 | ₹58.00 | +34.9% | ▼ Down |
| 3 | May 17, 2026 2:34 pm | +₹20.00 | ₹63.00 | +46.5% | – Flat |
| 4 | May 16, 2026 1:19 pm | +₹20.00 | ₹63.00 | +46.5% | – Flat |
| 5 | May 15, 2026 10:46 am | +₹20.00 | ₹63.00 | +46.5% | ▲ Up |
| 6 | May 14, 2026 5:18 pm | +₹15.00 | ₹58.00 | +34.9% | ▼ Down |
| 7 | May 13, 2026 11:34 pm | +₹25.00 | ₹68.00 | +58.1% | ▲ Up |
| 8 | May 12, 2026 2:51 pm | +₹18.00 | ₹61.00 | +41.9% | ▲ Up |
| 9 | May 11, 2026 6:36 pm | +₹17.00 | ₹60.00 | +39.5% | ▲ Up |
| 10 | May 10, 2026 12:52 pm | +₹16.00 | ₹59.00 | +37.2% | ▲ Up |
| 11 | May 09, 2026 10:37 pm | +₹15.00 | ₹58.00 | +34.9% | ▲ Up |
| 12 | May 08, 2026 12:17 pm | +₹8.00 | ₹51.00 | +18.6% | ▲ Up |
| 13 | May 07, 2026 4:20 pm | +₹0.00 | ₹43.00 | +0.0% | — |
Want to understand how GMP works and how to estimate listing price? Read our guide on What is GMP in IPO.
The latest Goldline Pharmaceutical IPO GMP is ₹15.00, recorded on 19 May 2026, 11:25 AM IST. At the ₹43 upper price band, this points to an estimated listing price of ₹58.00 (+34.9%).
Over the last 5 days with GMP data (15 May – 19 May 2026), the GMP moved from ₹20.00 to ₹15.00, a net change of −₹5.00 (−11.6% of the upper price band). That is a Falling trend by our definition: above +5% of the upper price band is rising, below −5% is falling, anything in between is stable.
The current GMP of ₹15.00 is +34.9% of the ₹43 upper price band (GMP ÷ upper price band × 100).
On 19 May 2026, the GMP closed at ₹15.00, unchanged from ₹15.00 on 18 May 2026.
The highest GMP we have recorded for Goldline Pharmaceutical IPO is ₹25.00, on 13 May 2026, 11:34 PM IST.
Over the last 5 days with GMP data, the Goldline Pharmaceutical IPO GMP ranged from ₹15.00 to ₹20.00.
At the current GMP of ₹15.00 and a lot size of 3,000 shares, the estimated profit is ₹45,000.00 per lot (GMP × lot size), before charges and taxes. It is indicative only.
Our team updates the Goldline Pharmaceutical IPO GMP manually through the day while the IPO is active. We have recorded 13 entries since 7 May 2026; the latest was on 19 May 2026, 11:25 AM IST.
GMP is an unofficial, unregulated indicator from the informal grey market. It reflects speculative pre-listing demand but can be manipulated or change rapidly. Use it as one data point alongside official subscription data, company financials, and valuation metrics. SEBI does not regulate grey market trading.
Goldline Pharmaceutical IPO is expected to list on May 19, 2026 on BSE SME platform.
Not reliably. GMP shows what grey market participants were willing to pay at a point in time; the listing price is set by demand on the exchange on listing day and can differ widely from the last GMP.
GMP is unofficial and unregulated. Past GMP accuracy varies. Use alongside subscription data and fundamentals.